MICHAEL POWELL Insider Trading $SYBX SYNLOGIC, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL POWELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL POWELL. MICHAEL POWELL is Director in Ocera Therapeutics, Inc. ($TZYM) and Director in Mirna Therapeutics, Inc. ($MIRN) and Director in Galera Therapeutics, Inc. ($GRTX) and Director in Checkmate Pharmaceuticals, Inc. ($CMPI).
MICHAEL POWELL in SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL POWELL: Director
Holdings: 574,972 shares
Current Value: $1,264,938
Latest Transaction: Jun 07 2019
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL POWELL in SYNLOGIC, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CMPI, GRTX, TZYM, SYBX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2019 | SYBX | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 7.30 | 10,000 | 73,000 | 10,000 | |
| Jun 14 2018 | SYBX | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 9.36 | 10,000 | 93,600 | 10,000 | |
| Jan 30 2018 | MIRN | SYNLOGIC, INC. | POWELL MICHAEL | Director | Grant | A | 9.75 | 150,000 | 1,462,500 | 574,972 | 425 K to 575 K (+35.30 %) |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | POWELL MICHAEL | Director | Option Exercise | A | 12.07 | 1,428 | 17,236 | 1,428 | |
| Sep 06 2016 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 4.74 | 10,000 | 47,400 | 10,000 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | C | 0.00 | 1,244,269 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,974,811 | 2.1 M to 3 M (+40.48 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Buy | J | 0.00 | 289,841 | 0 | 2,117,669 | 1.8 M to 2.1 M (+15.86 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Buy | C | 0.00 | 583,559 | 0 | 1,827,828 | 1.2 M to 1.8 M (+46.90 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Buy | C | 0.00 | 1,244,269 | 0 | 1,244,269 | 0 to 1.2 M |
| Sep 30 2015 | MIRN | Mirna Therapeutics ... | POWELL MICHAEL | Director | Option Exercise | A | 7.00 | 7,200 | 50,400 | 7,200 |
Page: 1